US6340368B1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Implantable device with radiopaque ends
Assignee: Medtronic Inc
•
Filing: 1998-10-23
•
Granted: 2002-01-22
•
Expires: 2018-10-23
Abstract
Abstract The present invention provides an implantable device for use in the treatment of at least partially obstructed body lumen. The implantable medical device includes at least one radiopaque tubular section attached to a first end of a tubular midsection. Upon viewing the device with x-ray, a three dimensional image is visible that allows for increased accuracy in assessing device placement, device sizing, device deployment, and even lumen orientation.
Inventors
- 👤 Marcel A. E Verbeck
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 00:22
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/82; A61F2/86; A61F2/90; A61F2/91; A61F2/915; A61F2002/91533; A61F2002/91541; A61F2002/9155; A61F2002/91558; A61F2230/00; A61F2230/0002; A61F2230/0028; A61F2230/0054; A61F2250/00; A61F2250/0058; A61F2250/0096; A61F2250/0098
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
120 words
An implantable medical device, comprising: a radiolucent tubular structure having a first end and a second end, the tubular structure being expandable from an initial diameter to a second diameter; and a tubular end structure being formed of a plurality of longitudinal elements and a plurality of horizontal connecting elements and having a first end and a second end, wherein the first end of the tubular end structure is connected to the first end of the radiolucent tubular structure, the tubular end structure being expandable from an initial diameter to a second diameter to provide a substantially uninterrupted passageway therethrough, wherein the tubular end structure consists of a radiopaque material viewable upon exposure to x-ray as a three dimensional structure.
Claim 2
Dependent Claim
120 words
An implantable medical device, comprising: a radiolucent tubular structure having a first end and a second end, the tubular structure being expandable from an initial diameter to a second diameter; and a tubular end structure being formed of a plurality of longitudinal elements and a plurality of horizontal connecting elements and having a first end and a second end, wherein the first end of the tubular end structure is connected to the first end of the radiolucent tubular structure, the tubular end structure being expandable from an initial diameter to a second diameter to provide a substantially uninterrupted passageway therethrough, wherein the tubular end structure consists of a radiopaque material viewable upon exposure to x-ray as a three dimensional structure.
Claim 3
Dependent Claim
55 words
The implantable medical device of claim 1 further comprising a second tubular end structure attached to the second end of the tubular structure, the second tubular end structure being expandable from an initial diameter to a second diameter to provide a substantially uninterrupted passageway therethrough, wherein the second tubular end structure comprises a radiopaque material.
Claim 4
Dependent Claim
17 words
The implantable device of claim 1 wherein the radiopaque material is more compliant than the radiolucent material.
Claim 5
Dependent Claim
24 words
The implantable device of claim 1 wherein the radiopaque material has a density of about 19.3 gm/cm 3 to about 21.0 gm/cm 3 .
Claim 6
Dependent Claim
24 words
The implantable device of claim 1 wherein the radiopaque material is selected from the group consisting of tantalum, gold, iridium, and a combination thereof.
Claim 7
Dependent Claim
28 words
The implantable device of claim 1 wherein the radiolucent midsection is formed from a material selected from the group of stainless steel, niobium, titanium, and a combination thereof.
Claim 8
Dependent Claim
24 words
The implantable device of claim 1 wherein the first tubular structure comprises less than about 25% of a total length of the implantable device.
Claim 9
Dependent Claim
201 words
An implantable medical device, comprising: a tubular structure having a first end and a second end, the tubular structure being expandable from an initial diameter to a second diameter, wherein the tubular structure is formed from a radiolucent material; a first tubular end structure being formed of a plurality of longitudinal elements and a plurality of horizontal connecting elements and having a first end and a second end, wherein the first end of the first tubular end structure is connected to the first end of the tubular structure, the first tubular end structure being expandable from an initial diameter to a second diameter; and a second tubular end structure being formed of a plurality of longitudinal elements and a plurality of horizontal connecting elements and having a first end and a second end, wherein the first end of the second tubular end structure is connected to the second end of the tubular structure, the second tubular end structure being expandable from an initial diameter to a second diameter to provide a substantially uninterrupted passageway from the first tubular end structure to the second tubular end structure, wherein the first and the second tubular end structures each consist of a radiopaque material.
Claim 10
Dependent Claim
201 words
An implantable medical device, comprising: a tubular structure having a first end and a second end, the tubular structure being expandable from an initial diameter to a second diameter, wherein the tubular structure is formed from a radiolucent material; a first tubular end structure being formed of a plurality of longitudinal elements and a plurality of horizontal connecting elements and having a first end and a second end, wherein the first end of the first tubular end structure is connected to the first end of the tubular structure, the first tubular end structure being expandable from an initial diameter to a second diameter; and a second tubular end structure being formed of a plurality of longitudinal elements and a plurality of horizontal connecting elements and having a first end and a second end, wherein the first end of the second tubular end structure is connected to the second end of the tubular structure, the second tubular end structure being expandable from an initial diameter to a second diameter to provide a substantially uninterrupted passageway from the first tubular end structure to the second tubular end structure, wherein the first and the second tubular end structures each consist of a radiopaque material.
Claim 11
Dependent Claim
17 words
The implantable device of claim 8 wherein the radiopaque material is more compliant than the radiolucent material.
Claim 12
Dependent Claim
24 words
The implantable device of claim 8 wherein the radiopaque material has a density of about 19.3 gm/cm 3 to about 21.0 gm/cm 3 .
Claim 13
Dependent Claim
24 words
The implantable device of claim 8 wherein the radiopaque material is selected from the group consisting of tantalum, gold, iridium, and a combination thereof.
Claim 14
Dependent Claim
24 words
The implantable device of claim 8 wherein the radiolucent material is selected from the group of stainless steel, niobium, titanium and a combination thereof.
Claim 15
Dependent Claim
30 words
The implantable device of claim 8 wherein the first tubular structure and the second tubular structure each comprise less than about 25% of a total length of the implantable device.
Claim 16
Dependent Claim
31 words
The implantable device of claim 8 wherein the first tubular structure and the second tubular structure each comprise about 20% to about 15% of a total length of the implantable device.
Claim 17
Dependent Claim
118 words
An implantable medical device, comprising: a radiolucent tubular structure having a first end and a second end, the tubular structure being expandable from an initial diameter to a second diameter; and a tubular end structure having a first end and a second end, wherein the first end of the first tubular end structure is connected to the first end of the radiolucent tubular structure, the tubular end structure being expandable from an initial diameter to a second diameter to provide a substantially uninterrupted passageway therethrough and being 15% to 20% of a total length of the implantable device, wherein the tubular end structure consists of a radiopaque material viewable upon exposure to x-ray as a three dimensional structure.
Claim 18
Dependent Claim
118 words
An implantable medical device, comprising: a radiolucent tubular structure having a first end and a second end, the tubular structure being expandable from an initial diameter to a second diameter; and a tubular end structure having a first end and a second end, wherein the first end of the first tubular end structure is connected to the first end of the radiolucent tubular structure, the tubular end structure being expandable from an initial diameter to a second diameter to provide a substantially uninterrupted passageway therethrough and being 15% to 20% of a total length of the implantable device, wherein the tubular end structure consists of a radiopaque material viewable upon exposure to x-ray as a three dimensional structure.
Claim 19
Dependent Claim
196 words
An implantable medical device, comprising: a tubular structure having a first end and a second end, the tubular structure being expandable from an initial diameter to a second diameter, wherein the tubular structure is formed from a radiolucent material; a first tubular end structure having a first end and a second end, wherein the first end of the first tubular end structure is connected to the first end of the tubular structure, the first tubular end structure being expandable from an initial diameter to a second diameter and being 15% to 20% of a total length of the implantable device; and a second tubular end structure having a first end and a second end, wherein the first end of the second tubular end structure is connected to the second end of the tubular structure, the second tubular end structure being expandable from an initial diameter to a second diameter to provide a substantially uninterrupted passageway from the first tubular end structure to the second tubular end structure and being 15% to 20% of a total length of the implantable device, and wherein the first and the second tubular end structures each consist of a radiopaque material.
Claim 20
Dependent Claim
196 words
An implantable medical device, comprising: a tubular structure having a first end and a second end, the tubular structure being expandable from an initial diameter to a second diameter, wherein the tubular structure is formed from a radiolucent material; a first tubular end structure having a first end and a second end, wherein the first end of the first tubular end structure is connected to the first end of the tubular structure, the first tubular end structure being expandable from an initial diameter to a second diameter and being 15% to 20% of a total length of the implantable device; and a second tubular end structure having a first end and a second end, wherein the first end of the second tubular end structure is connected to the second end of the tubular structure, the second tubular end structure being expandable from an initial diameter to a second diameter to provide a substantially uninterrupted passageway from the first tubular end structure to the second tubular end structure and being 15% to 20% of a total length of the implantable device, and wherein the first and the second tubular end structures each consist of a radiopaque material.
References Cited (Backward Citations)
US269882A
Cited
US308368A
Cited
US3618614A
Cited
US3757768A
Cited
US4202349A
Cited
US4430086A
Cited
US4345602A
Cited
US4279252A
Cited
US4657024A
Cited
US4588399A
Cited
US4662404A
Cited
US4464176A
Cited
US4469483A
Cited
US4545390A
Cited
US4456017A
Cited
USRE33911E
Cited
US4538622A
Cited
US5562728A
Cited
US5275622A
Cited
EP0146699A1
Cited
US4636346A
Cited
US4617932A
Cited
US4577637A
Cited
US4619274A
Cited
US4721117A
Cited
US4798598A
Cited
US4938220A
Cited
US4763647A
Cited
US4821722A
Cited
US4757827A
Cited
US4815478A
Cited
US5105818A
Cited
US4793359A
Cited
US4796637A
Cited
US4817613A
Cited
US4886062A
Cited
US4867174A
Cited
US4846186A
Cited
US4895168A
Cited
US4873983A
Cited
US4884579A
Cited
US4898591A
Cited
EP0649637A1
Cited
US5456251A
Cited
US4906244A
Cited
US5464438A
Cited
US5065769A
Cited
US5081997A
Cited
US4957110A
Cited
US4922924A
Cited
US5063935A
Cited
US5171232A
Cited
US5171232B1
Cited
US5045072A
Cited
US4981470A
Cited
US5129890A
Cited
US4990138A
Cited
US5144959A
Cited
US5084022A
Cited
US5209730A
Cited
US5095915A
Cited
US5147315A
Cited
US5147317A
Cited
US5034005A
Cited
US5069217A
Cited
EP0680734A3
Cited
US5040543A
Cited
US5250034A
Cited
EP0480667B1
Cited
US5178158A
Cited
US5211636A
Cited
US5160559A
Cited
US5174302A
Cited
US5176149A
Cited
US5184627A
Cited
US5489295A
Cited
EP0508473B1
Cited
US5366442A
Cited
US5228453A
Cited
US5256158A
Cited
EP0519214A1
Cited
US5489277A
Cited
US5234416A
Cited
EP0517075B1
Cited
EP0519604B1
Cited
US5221270A
Cited
US5769830A
Cited
US5151105A
Cited
US5387235A
Cited
US5562726A
Cited
US5253653A
Cited
US5484418A
Cited
US5405004A
Cited
US5259393A
Cited
US5366504A
Cited
US5584821A
Cited
US5366473A
Cited
US5267574A
Cited
US5300025A
Cited
US5342348A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2005-01-21 | 2005-07-23 | 2006-01-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2009-01-21 | 2009-07-23 | 2010-01-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2013-01-21 | 2013-07-23 | 2014-01-22 | $7700.00 | Window Closed / Lapsed |